Not a good buy right now: price (24.2) is pushing into a resistance zone (above R1 24.082 with R2 at 24.377), while momentum signals are mixed.
Best setup is more favorable on a pullback toward the pivot/support area (~23.60–23.13) or a clean breakout/hold above ~24.38.
Fundamentals are solid (double-digit YoY growth in Q3 2025), but without a clear technical trigger or proprietary signal today, the risk/reward at current levels is only average.
Technical Analysis
Trend/Momentum: MACD histogram is slightly negative (-0.00962) but contracting (bearish momentum is fading); RSI(6) ~62 suggests mild bullish pressure but not an overbought breakout condition.
Moving averages: converging MAs indicate consolidation/indecision rather than a strong trend.
Price location: trading just under/into the next resistance (R2), which often limits immediate upside unless volume/momentum expands.
Pattern-based forward odds (from similar candlesticks): ~50% chance of +0.66% next day, +3.58% next week, +16.89% next month—constructive bias, but not a timing signal.
shows strong YoY growth in revenue, net income, and EPS.
Neutral/Negative Catalysts
Margin pressure: gross margin fell to 27.61% (down ~1.81% YoY), which can cap multiple expansion if it persists.
Technical overhead: price is near resistance (R2 ~24.377); failed breakout attempts often lead to mean reversion toward pivot/support.
Sentiment/flow: Hedge funds and insiders are reported as neutral (no supportive accumulation signal).
Financial Performance
Latest quarter provided: 2025/Q3.
Revenue: 39.95M, up 18.66% YoY (strong top-line growth).
Net income: 4.222M, up 21.39% YoY (profit growth outpacing revenue).
EPS: 0.34, up 21.43% YoY.
Gross margin: 27.61%, down 1.81% YoY (key watch item; suggests cost/input pressure or mix shift).
Growth
Profitability
Efficiency
Analyst Ratings and Price Target Trends
No analyst rating changes or price target updates were provided in the dataset.
Wall Street pro view (based on available data): Pros—clear YoY growth in revenue/earnings; Cons—margin compression and no clear momentum/flow catalyst at current resistance levels.
Influential buying/selling: No recent congress trading data available; insiders reported as neutral (no meaningful recent trend).
Wall Street analysts forecast CIX stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for CIX is 0 USD with a low forecast of 0 USD and a high forecast of 0 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
Analyst Rating
0
Wall Street analysts forecast CIX stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for CIX is 0 USD with a low forecast of 0 USD and a high forecast of 0 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
